Our findings confirmed the inflammatory effects of IL-23 and the immune regulatory role of IL-27 in GBS, and provide new insight into the regulation of inflammatory responses during the pathogenic and recovery processes of GBS. This evidence concerns the gene IL23A and Guillain-Barre syndrome.